Fermenta Biotech Limited has informed the Exchange about Press Release regarding exclusive Licence Agreement with Vellore Institute of Technology ( VIT ), Vellore for Vitamin B12 Fortification Technology.
Fermenta Biotech has announced a board meeting on August 11, 2026, which approved the financial results for the quarter ended June 30, 2026. Standalone revenue was ₹111.84 Cr, profit ₹14.99 Cr. Consolidated revenue reached ₹121.82 Cr, profit ₹9.53 Cr. The company also reversed a ₹2.05 Cr inventory provision and granted...
Fermenta Biotech officials will participate in one-to-one meetings with investors in Mumbai. No unpublished price sensitive information is expected to be discussed.
Fermenta Biotech Limited has informed the Exchange about Copy of Newspaper Publication pertaining to notice for Special Window for Transfer and Dematerialisation of Physical Securities.
Fermenta Biotech officials will attend a one-to-one investor meeting in Mumbai. Discussions will cover company information available on their website and stock exchanges; no unpublished price-sensitive information will be shared.
